Dipti Amin is currently a director at Maaya Associates Limited. Previously she was Senior Vice President and Chief Compliance Officer at Quintiles Transnational (recently rebranded as IQVIA). Over the last 25 years Dipti has held positions of operational and strategic responsibility within Pharmaceutical Services at the C-suite and board level, delivering consistently on growth, quality, customer, employee and process targets in businesses of £50-£500 million. Her broad and significant experience covers clinical pharmacology, as a Principal Investigator in Phase I clinical pharmacology studies, ethical issues in clinical research, drug development, ethics and compliance programmes as well as leadership and management of large, multi-functional, multi-geography groups.
Dipti has a medical degree from Guys and St. Thomas' Medical School, and multiple post-graduate qualifications and clinical experience in clinical pharmacology, paediatric medicine, care of the elderly medicine, obstetrics and gynaecology, and general practice as well as becoming a Member of the Royal College of General Practitioners and a Fellow of the Faculty of Pharmaceutical Medicine. Dipti is an Honorary Lecturer in Clinical Pharmacology at Guy's, King's, and St. Thomas' Hospitals Medical & Dental Schools, and a Non-Executive Director on the Buckinghamshire NHS Trust Board. Previously she served on the Board of the Faculty of Pharmaceutical Medicine, the Innovation Board of the Association of the British Pharmaceutical Industry, and the Emerging Science and Bioethics Advisory Committee of the Dept. of Health.